Studies on the physiological functions of the melanocortin system. Cone RD (2006) Endocr Rev 27: 736-49 Cancer cachexia: getting to the heart of the matter. Groarke JD, Cheng S, Jones LW, Moslehi J (2019) Eur Heart J 40: e17-e19 Role of leptin and melanocortin signaling in uremia-associated cachexia. Cheung W, Yu PX, Little BM, Cone RD, Marks DL, Mak RH (2005) J Clin Invest 115: 1659-65 Metabolic approaches to cancer cachexia. Lawson DH, Richmond A, Nixon DW, Rudman D (1982) Annu Rev Nutr 2: 277-301 A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Fouque D, Kalantar-Zadeh K, Kopple J, Cano N, Chauveau P, Cuppari L, Franch H, Guarnieri G, Ikizler TA, Kaysen G, Lindholm B, Massy Z, Mitch W, Pineda E, Stenvinkel P, Treviño-Becerra A, Trevinho-Becerra A, Wanner C (2008) Kidney Int 73: 391-8 Leptin and inflammation-associated cachexia in chronic kidney disease. Mak RH, Cheung W, Cone RD, Marks DL (2006) Kidney Int 69: 794-7 Inhibition of cisplatin-induced lipid catabolism and weight loss by ghrelin in male mice. Garcia JM, Scherer T, Chen JA, Guillory B, Nassif A, Papusha V, Smiechowska J, Asnicar M, Buettner C, Smith RG (2013) Endocrinology 154: 3118-29 Modulation of the acute phase response by altered expression of the IL-1 type 1 receptor or IL-1ra. Josephs MD, Solorzano CC, Taylor M, Rosenberg JJ, Topping D, Abouhamze A, Mackay SL, Hirsch E, Hirsh D, Labow M, Moldawer LL (2000) Am J Physiol Regul Integr Comp Physiol 278: R824-30 Nutrition support for the chronically wasted or acutely catabolic chronic kidney disease patient. Ikizler TA (2009) Semin Nephrol 29: 75-84
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.